News Formal

Business Maverick: Pfizer picks China firm involved in drug recall for Covid pill

  • 📰 dailymaverick
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 84%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The pharmaceutical giant has picked a Chinese drug-making giant once embroiled in a global medicines recall for supplying tainted ingredients to make its Covid-19 antiviral pill in the country.

Zhejiang Huahai Pharmaceutical will produce and sell Paxlovid in mainland China for five years, the companies said in separate statements. Pfizer will provide ingredients to make nirmatrelvir, the antiviral portion of the drug, and ritonavir, which slows the antiviral’s breakdown in the body. Huahai will manufacture and combine the two into Paxlovid.

Based in eastern China, Huahai is one of the nation’s biggest producers of pharmaceutical ingredients and generic drugs. In 2018, a likely carcinogen called NDMA was found in ingredients that the company manufactured and used in medicines to treat high blood pressure.

Pfizer has a rigorous quality system in place to ensure that medicines are produced in accordance with all applicable company and regulatory standards, a spokesperson said in response to questions from Bloomberg News about the Paxlovid agreement. Calls to a phone number listed on Huahai’s website went unanswered.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 3. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Zoom’s enterprise bet is delayed as company cuts sales forecastZoom Video Communications Inc.’s results showed that its transition from an essential Covid-era tool to an enterprise business platform is going to take longer than expected.
ソース: BusinessTechSA - 🏆 24. / 61 続きを読む »